Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

NCT00907036 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: alemtuzumab
BIOLOGICAL: donor lymphocytes
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: melphalan
PROCEDURE: allogeneic hematopoietic stem cell transplantation

Sponsor

Cancer Research UK